Medical Device Clinical Studies Course Online: EU MDR, PMCF, and Adverse Event Reporting (Mar 16th - 17th, 2027)

Master MDR clinical evaluations, investigations, PMCF studies and adverse event reporting, with insight into post Brexit device management across the EU & UK


Dublin, Nov. 16, 2026 (GLOBE NEWSWIRE) -- "Medical Device Studies: Regulatory Requirements and Adverse Event Reporting (Mar 16th - Mar 17th, 2027)" has been added to ResearchAndMarkets.com's offering.

This medical device clinical evaluation course provides a focused overview of clinical evaluations, clinical investigations and post-market clinical follow-up (PMCF) studies, with particular emphasis on adverse event reporting requirements. Designed for professionals involved in medical device compliance, clinical research and regulatory affairs, the course examines key responsibilities across the clinical evidence lifecycle and supports a clearer understanding of the regulatory expectations applying to medical device studies.

The programme concentrates primarily on the Medical Device Regulations (MDR), while also referring to relevant requirements under the existing Medical Device Directives. Participants will explore how the regulatory framework affects the planning, management and oversight of clinical activities, including the collection, review and reporting of clinical data. The content places adverse event reporting at the centre of the discussion, helping attendees consider how reporting obligations apply during clinical evaluations, clinical investigations and PMCF studies.

Clinical evidence remains a critical component of medical device regulatory compliance. This course addresses the relationship between clinical evaluations, investigations and PMCF activities, enabling participants to develop a more connected view of the processes used to support device safety, performance and ongoing regulatory compliance. It also highlights the importance of maintaining appropriate clinical documentation and ensuring that relevant information is managed in line with applicable requirements.

The course includes consideration of adverse events arising during medical device studies. Participants will review the regulatory context for identifying, assessing and reporting events, alongside the responsibilities associated with clinical study oversight. This emphasis is intended to strengthen awareness of reporting requirements and support consistent regulatory practices throughout clinical activities.

In addition to its focus on the MDR, the programme reviews the implications of post Brexit arrangements for medical device management in the EU & UK. This section considers the evolving regulatory environment and the practical importance of understanding different requirements across the two markets. For organisations operating internationally, awareness of the EU & UK frameworks is essential when managing clinical evidence, regulatory documentation and post-market activities.

The course is relevant to professionals working in medical device regulatory affairs, clinical affairs, quality assurance, clinical research, compliance and post-market surveillance. It may also benefit personnel responsible for clinical evaluation reports, clinical investigation activities, PMCF planning, adverse event reporting or the coordination of medical device studies. The programme offers a structured opportunity to consolidate knowledge of interconnected clinical and regulatory responsibilities.

By completing the course, participants will gain an updated overview of medical device clinical evaluations, clinical investigations and PMCF studies, supported by discussion of the applicable regulatory landscape. The combination of MDR content, references to the Medical Device Directives and consideration of post Brexit implications provides a broad perspective on current medical device management in the EU & UK.

The programme is intended to support continuing professional development for individuals seeking to strengthen their knowledge of medical device clinical evidence and adverse event reporting. Its focused content helps attendees review key regulatory considerations while developing greater confidence in the requirements that influence clinical study management and compliance.

CPD Hours: 12

Who should attend?

  • Regulatory affairs specialists
  • Quality assurance specialists
  • Clinical research associates
  • Junior clinical research associates
  • Professionals involved in reporting adverse events during pre- and post-market clinical studies

Key Topics Covered:

  • Day 1
    • Clinical evaluation - an overview
    • Clinical investigations - an overview
    • PMS and PMCF
    • Quiz on clinical evaluation, clinical investigation and PMCF
    • New requirements of the MDR
    • The competent authority and the Notified Body
    • Workshop on the new requirements of the MDR
  • Day 2
    • Vigilance reporting
    • How to define and classify adverse events
    • Vigilance workshop
    • The regulatory requirements for monitoring and reporting adverse events during regulatory and PMCF studies
    • The MDR - clinical elements

Speaker

Graeme Ladds

Graeme Ladds, Director of PharSafer, has over 30 years' experience in the pharmaceutical industry. He began his career in 1989 at Ashbourne Pharmaceuticals as Head of Drug Safety & Medical Information, before going on to become Head of Global Pharmacovigilance at Shire Pharmaceuticals.

He later founded his consultancy and specialist CRO, PharSafer Associates Ltd, where he has supported companies in establishing pharmacovigilance systems, conducting audits across Europe and the USA, developing SOPs, acting as a QP, and supporting regulatory inspections.

Since 1994, Graeme has also been involved in the monitoring of medical devices, including drug-device combinations, structural devices and electrical medical devices. His experience spans clinical trials and global device vigilance, alongside pharmacovigilance activities across both clinical development and post-marketing phases.

For more information about this training visit https://www.researchandmarkets.com/r/ibbwk5

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Contact Data

GlobeNewswire

Recommended Reading